Shannon Timothy M
SEC-identified person · CIK 1207114 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Ideaya Biosciences, Inc. IDYA | Director | filed 2019 - 2023 |
| Arvinas, INC. AVRN | Director | filed 2018 - 2022 |
| Rallybio Corp RLYB | Director | filed 2021 - 2022 |
| Nextcure, Inc. NXTC | Director | filed 2019 - 2019 |
| Cytomx Therapeutics, Inc. CTMX | Director | filed 2015 - 2016 |
| Celldex Therapeutics, Inc. CLDX | Director | filed 2009 - 2014 |
| Curagen Corp CRGN | Director · President and CEO | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.